Long, R., Guo, H., & Chen, K. Cost-effectiveness analysis of nimotuzumab combined with gemcitabine for K-Ras wild type locally advanced or metastatic pancreatic cancer in China. Nature Portfolio.
Chicago Style (17th ed.) CitationLong, Rong, Hao Guo, and Kun Chen. Cost-effectiveness Analysis of Nimotuzumab Combined with Gemcitabine for K-Ras Wild Type Locally Advanced or Metastatic Pancreatic Cancer in China. Nature Portfolio.
MLA (9th ed.) CitationLong, Rong, et al. Cost-effectiveness Analysis of Nimotuzumab Combined with Gemcitabine for K-Ras Wild Type Locally Advanced or Metastatic Pancreatic Cancer in China. Nature Portfolio.
Warning: These citations may not always be 100% accurate.